Treatment Outcomes and Prognostic Factors of Acute Variceal Bleeding in Patients with Hepatocellular Carcinoma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The treatment outcomes and prognostic markers of acute variceal bleeding (AVB) in hepatocellular carcinoma (HCC) patients remain unclear. Therefore, we evaluated the clinical outcomes and prognostic factors of AVB in HCC patients. Methods: Cirrhotic patients with endoscopically confirmed AVB between 2007 and 2013 were enrolled in this prospective study. Prognostic factors were identified by multivariate Cox proportional hazards regression analysis. Results: Among the 329 enrolled patients, 125 patients (38.0%) were diagnosed with HCC. The 6-week mortality rates of all enrolled AVB patients and the HCC subgroup were 14.9% and 26.4%. The 5-day treatment failure, 6-week mortality, cirrhosis-related complications, and duration of hospitalization were greater in HCC patients than in non-HCC patients (all p<0.05). In the HCC subgroup, the Model for End-Stage Liver Disease (MELD) score (hazard ratio [HR], 1.145; p=0.001) and Barcelona Clinic Liver Cancer (BCLC) stage (C–D vs 0–B) (HR, 3.096; p=0.019) were independent predictors of 6-week mortality. Our study revealed that 85% of HCC patients with both a MELD score ≥15.5 and BCLC stage C–D died within 6 weeks, and the 6-week mortality risk was 21-fold higher in this group than in the group with a lower MELD score and earlier HCC stage (p<0.001). Conclusions: The 5-day treatment failure and 6-week mortality rates were significantly higher among AVB patients with HCC than those without HCC. The MELD score and the presence and stage of HCC are strong predictors of 6-week mortality in patients with AVB.
Abstract
Background/Aims: The treatment outcomes and prognostic markers of acute variceal bleeding (AVB) in hepatocellular carcinoma (HCC) patients remain unclear. Therefore, we evaluated the clinical outcomes and prognostic factors of AVB in HCC patients. Methods: Cirrhotic patients with endoscopically confirmed AVB between 2007 and 2013 were enrolled in this prospective study. Prognostic factors were identified by multivariate Cox proportional hazards regression analysis. Results: Among the 329 enrolled patients, 125 patients (38.0%) were diagnosed with HCC. The 6-week mortality rates of all enrolled AVB patients and the HCC subgroup were 14.9% and 26.4%. The 5-day treatment failure, 6-week mortality, cirrhosis-related complications, and duration of hospitalization were greater in HCC patients than in non-HCC patients (all p<0.05). In the HCC subgroup, the Model for End-Stage Liver Disease (MELD) score (hazard ratio [HR], 1.145; p=0.001) and Barcelona Clinic Liver Cancer (BCLC) stage (C–D vs 0–B) (HR, 3.096; p=0.019) were independent predictors of 6-week mortality. Our study revealed that 85% of HCC patients with both a MELD score ≥15.5 and BCLC stage C–D died within 6 weeks, and the 6-week mortality risk was 21-fold higher in this group than in the group with a lower MELD score and earlier HCC stage (p<0.001). Conclusions: The 5-day treatment failure and 6-week mortality rates were significantly higher among AVB patients with HCC than those without HCC. The MELD score and the presence and stage of HCC are strong predictors of 6-week mortality in patients with AVB.
참고문헌 (27)
- Graham DY, "The course of patients after variceal hemorrhage", Gastroenterology, 80, pp.800~809 (1981)
- De Franchis R, "Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension", J Hepatol, 53, pp.762~768 (2010)
- Chalasani N, "Improved patient survival after acute variceal bleeding : a multicenter, cohort study", Am J Gastroenterol, 98, pp.653~659 (2003)
- Carbonell N, "Improved survival after variceal bleeding in patients with cirrhosis over the past two decades", Hepatology, 40, pp.652~659 (2004)
- García-Pagán JC, "Early use of TIPS in patients with cirrhosis and variceal bleeding", N Engl J Med, 362, pp.2370~2379 (2010)
- Jin Wook Chung, "Role of endoscopic treatment or balloon-occluded retrograde transvenous obliteration in patients with Child-Pugh class C end-stage liver cirrhosis and esophageal", gastric varices, 2019, pp.25(2), 181~182[DOI]
- Garcia-Tsao G, "Management of varices and variceal hemorrhage in cirrhosis", N Engl J Med, 362, pp.823~832 (2010)
- Jairath V, "Acute variceal haemorrhage in the United Kingdom : patient characteristics, management and outcomes in a nationwide audit", Dig Liver Dis, 46, pp.419~426 (2014)
- Bambha K, "Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis", Gut, 57, pp.814~820 (2008)
- Abraldes JG, "Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy", J Hepatol, 48, pp.229~236 (2008)
- Augustin S, "Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis", Clin Gastroenterol Hepatol, 7, pp.1347~1354 (2009)
- Amitrano L, "MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices", J Hepatol, 42, pp.820~825 (2005)
- Chen PH, "Delayed endoscopy increases re-bleeding and mortality in patients with hematemesis and active esophageal variceal bleeding : a cohort study", J Hepatol, 57, pp.1207~1213 (2012)
- Augustin S, "Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleeding", Am J Gastroenterol, 106, pp.1787~1795 (2011)
- Lecleire S, "Acute upper gastrointestinal bleeding in patients with liver cirrhosis and in noncirrhotic patients : epidemiology and predictive factors of mortality in a prospective multicenter population-based study", J Clin Gastroenterol, 39, pp.321~327 (2005)
- Han ML, "Predictors of in-hospital mortality after acute variceal bleeding in patients with hepatocellular carcinoma and concurrent main portal vein thrombosis", J Gastroenterol Hepatol, 29, pp.344~351 (2014)
- Wiesner R, "Model for end-stage liver disease(MELD)and allocation of donor livers", Gastroenterology, 124, pp.91~96 (2003)
- Chalasani N, "Model for End-Stage Liver Disease(MELD)for predicting mortality in patients with acute variceal bleeding", Hepatology, 35, pp.1282~1284 (2002)
- Reverter E, "A MELD-based model to determine risk of mortality among patients with acute variceal bleeding", Gastroenterology, 146, pp.412~419 (2014)
- Sarin SK, "Diagnosis and management of acute variceal bleeding : Asian Pacific Association for Study of the Liver recommendations", Hepatol Int, 5, pp.607~624 (2011)
- Hou MC, "Clinical implications of the white nipple sign and its role in the diagnosis of esophageal variceal hemorrhage", Am J Gastroenterol, 91, pp.2103~2109 (1996)
- Forner A, "Hepatocellular carcinoma", Lancet, 379, pp.1245~1255 (2012)
- De Franchis R, "Evolving consensus in portal hypertension : report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension", J Hepatol, 43, pp.167~176 (2005)
- Idezuki Y, "General rules for recording endoscopic findings of esophagogastric varices (1991). Japanese Society for Portal Hypertension", World J Surg, 19, pp.420~423 (1995)
- Amitrano L, "The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients : refining short-term prognosis and risk factors", Am J Gastroenterol, 107, pp.1872~1878 (2012)
- Lo GH, "Controlled trial of ligation plus vasoconstrictor versus proton pump inhibitor in the control of acute esophageal variceal bleeding", J Gastroenterol Hepatol, 28, pp.684~689 (2013)
- Lo EA, "Use of proton pump inhibitors in the management of gastroesophageal varices : a systematic review", Ann Pharmacother, 49, pp.207~219 (2015)